SEC Company Response from Merck & Co., Inc. (MRK) (CIK 0000310158) (MRK) — Jun 24, 2009
Merck & Co., Inc. (MRK) (CIK 0000310158)
Date: June 24, 2009 · CIK: 0000310158 · Accession: 0000950123-09-016832
AI Filing Summary & Sentiment
File numbers found in text: 333-159371
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
[Schering-Plough Corporation Letterhead]
June 24, 2009
VIA EDGAR AND FACSIMILE
Jeffrey Riedler
Assistant Director
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Mail Stop 4720
Washington, D.C. 20549
Re:
Schering-Plough Corporation
Form S-4, as amended
Filed June 24, 2009
File No. 333-159371
Dear Mr. Riedler:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended,
Schering-Plough Corporation, a New Jersey corporation (the “Registrant”), hereby requests
that the effectiveness under the Securities Act of 1933, as amended, of the above-captioned
Registration Statement be accelerated to 5:00 p.m., Eastern time, on June 24, 2009 or as soon
thereafter as practicable.
In connection with the foregoing request for acceleration of effectiveness, the Registrant
hereby acknowledges the following:
•
should the U.S. Securities and Exchange Commission (the “Commission”) or the staff,
acting pursuant to delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated authority,
in declaring the filing effective, does not relieve the Registrant from its full
responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Registrant may not assert the declaration of effectiveness as a defense in any
proceeding initiated by the Commission or any person under the federal securities laws
of the United States.
* * * * * *
Please contact the undersigned at Schering-Plough Corporation at (908) 298-7119 or, in my
absence, Susan Ellen Wolf at (908) 298-7354, with any questions you may have concerning this
request. In addition, please notify the undersigned when this request for acceleration has been
granted.
Sincerely,
/s/ Michael Pressman
Michael Pressman
Senior Counsel
cc:
Susan Ellen Wolf, Schering-Plough Corporation
Celia A. Colbert, Merck & Co., Inc.
Nandini Acharya, SEC
Suzanne Hayes, SEC
-2-